Fevipiprant, a Selective Prostaglandin-D2 Receptor-2 Antagonist, Inhibits Human Group-2 Innate Lymphoid Cell Aggregation and Function

Journal of Allergy and Clinical Immunology - United States
doi 10.1016/j.jaci.2019.02.015

Related search